During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
GHKCu helps reverse this by stimulating collagen and elastin at the cellular level
TGR inhibitors have efficacy as schistosomicidal agents in vivo Encouraged by the activity of our non-covalent TGR inhibitors against ex vivo worms, we evaluated the schistosomicidal activity of these compounds in mice infected with S
Funding This research was supported by the National Natural Science Foundation of China (82372618, 82573843, 82302918, 82273287, 82403142, 82404671)
